News

“Wrinkles on the neck can be improved with various treatments, including topical creams, in-office procedures such as laser ...
On behalf of our sponsors at Arcutis Biotherapeutics, we're learning more about Plaque Psoriasis, the chronic, inflammatory skin disease that affects many people and a new topical treatment that may ...
Neck ultrasound, on its own, is inadequate for a thorough assessment of nonpalpable lymph nodes in head and neck cancer staging. Nevertheless, it could serve as the sole imaging option in low-resource ...
Skin cells taken from human psoriasis patients, reconstructed into tissue and grafted onto immunodeficient mice, "showed pronounced psoriasiform hyperplasia" when treated with a placebo solution ...
The face may get all the attention when it comes to cosmetic treatments, but the neck deserves love too. Novel technologies that go beyond creams deliver lifted, sculpted necks—without surgery.
A new consensus from the National Psoriasis Foundation outlines a clear benchmark for remission to improve treatment decisions and patient outcomes.
Former talk show host Ricki Lake openly discusses her lower face and neck lift, calling it "the best facelift," while advocating against stigma around cosmetic procedures.
The Food and Drug Administration approved Merck's treatment for certain head and neck cancers. The Rahway, N.J., drug maker said Friday that its treatment, Keytruda, has been approved for adult ...
Abstract Head and neck squamous cell carcinoma (HNSCC) remains a globally prevalent malignancy with high morbidity and mortality. Despite therapeutic advances, patient outcomes are hindered by tumor ...
Abdominal obesity is a greater risk factor for psoriasis than total body fat, according to an analysis of imaging data, suggesting clinicians should consider treatments that also reduce ...
Dr. Jason Rivers, MD, FRCPC, discusses psoriasis symptoms and treatments. Trump’s Strike On Iran Draws Mixed Reactions From U.S. Lawmakers TV Host Reveals He's Had 4 Hair Transplants ― And Has ...
Arcutis Biotherapeutics has received FDA approval for ZORYVE (roflumilast) topical foam 0.3%, which is now available for treating plaque psoriasis on the scalp and body in patients aged 12 and ...